Aire Advisors, LLC Amgen Inc Transaction History

Aire Advisors, LLC

$443 Million
Q3 2024

A detailed history of Aire Advisors, LLC transactions in Amgen Inc stock. As of the latest transaction made, Aire Advisors, LLC holds 10,518 shares of AMGN stock, worth $2.8 Million. This represents 0.77% of its overall portfolio holdings.

Number of Shares

10,518

Previous 10,570 0.49%

Holding current value

$2.8 Million

Previous $3.3 Million 2.63%

% of portfolio

0.77%

Previous 0.77%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$309.38 - $337.38 $16,087 - $17,543	-52 Reduced 0.49%	10,518 $3.39 Million
Q2 2024 Aug 01, 2024	BUY	$262.75 - $319.31 $19,443 - $23,628	74 Added 0.71%	10,570 $3.3 Million
Q1 2024 May 13, 2024	BUY	$268.87 - $324.56 $25,811 - $31,157	96 Added 0.92%	10,496 $2.98 Million
Q4 2023 Jan 29, 2024	SELL	$255.7 - $288.46 $45,003 - $50,768	-176 Reduced 1.66%	10,400 $3 Million
Q3 2023 Oct 30, 2023	BUY	$218.65 - $271.46 $12,900 - $16,016	59 Added 0.56%	10,576 $2.84 Million
Q2 2023 Aug 02, 2023	BUY	$214.27 - $253.37 $19,712 - $23,310	92 Added 0.88%	10,517 $2.33 Million
Q1 2023 May 15, 2023	BUY	$225.79 - $275.2 $13,773 - $16,787	61 Added 0.59%	10,425 $2.52 Million
Q4 2022 Feb 13, 2023	SELL	$229.03 - $291.01 $62,525 - $79,445	-273 Reduced 2.57%	10,364 $2.72 Million
Q3 2022 Oct 28, 2022	BUY	$224.46 - $253.15 $54,992 - $62,021	245 Added 2.36%	10,637 $2.4 Million
Q2 2022 Aug 08, 2022	BUY	$230.71 - $256.74 $5,767 - $6,418	25 Added 0.24%	10,392 $2.53 Million
Q1 2022 May 06, 2022	BUY	$219.27 - $242.57 $138,140 - $152,819	630 Added 6.47%	10,367 $2.51 Million
Q4 2021 Feb 09, 2022	BUY	$198.88 - $227.6 $1.94 Million - $2.22 Million	9,737 New	9,737 $2.19 Million

Others Institutions Holding AMGN

# of Institutions

3,126

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $142B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Aire Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aire Advisors, LLC with notifications on news.

Account

Aire Advisors, LLC Amgen Inc Transaction History